Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05471609 · ClinicalTrials.gov registry record · Early Phase 1

Sustained Release Oral Formulation for Treatment of Parkinson's Disease

A Early Phase 1 study of Healthy Volunteers, sponsored by University of Minnesota.

Recruiting
Registry status
Early Phase 1
Development phase
6
Enrollment target
1
Study location

NCT05471609 is a Early Phase 1 study of Healthy Volunteers that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 6 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05471609, a Early Phase 1 study of Healthy Volunteers, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
Early Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Achieving sustained blood levels of carbidopa/levodopa has been a challenge in the treatment of PD and although levodopa remains the most commonly used drug, motor fluctuations remain a major disability especially in advanced Parkinson's disease. The aim of this study is to determine the efficacy of a novel oral carbidopa-levodopa formulation in achieving a sustained blood level of levodopa and carbidopa in normal volunteers.

Conditions Studied

Healthy Volunteers

Interventions

  • DRUG levodopa/carbidopa oral formulation A
  • DRUG levodopa/carbidopa oral formulation B

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2025-06-12
Est. Completion 2026-06-16
Phase Early Phase 1

Sponsor

University of Minnesota

966 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05471609

The ClinicalTrials.gov registry entry for NCT05471609 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (99% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which levodopa/carbidopa oral formulation A is the first listed.

NCT05471609 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05471609 about?

NCT05471609 is a clinical study titled "Sustained Release Oral Formulation for Treatment of Parkinson's Disease". Achieving sustained blood levels of carbidopa/levodopa has been a challenge in the treatment of PD and although levodopa remains the most commonly used drug, motor fluctuations remain a major disability especially in advanced Parkinson's disease. The aim of this study is to determine the efficacy of...

What is the current status of trial NCT05471609?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2025-06-12. Estimated completion is 2026-06-16.

What conditions does trial NCT05471609 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT05471609?

The interventions under investigation include: levodopa/carbidopa oral formulation A (DRUG), levodopa/carbidopa oral formulation B (DRUG).

Who is sponsoring clinical trial NCT05471609?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05471609 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy Volunteers

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.